MedTrace Logo

Sepsis Prognosis and Diagnosis in the Emergency Department (SPEED)

NCT05639504 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2023-12-27

No results posted yet for this study

Summary

This study aims to evaluate the diagnostic and prognostic performance of a novel mRNA diagnostic/prognostic classifier (interprets the expression of 29 host response mRNA biomarkers) from whole blood in adult patients presenting to emergency departments (ED) with suspected infection.

Conditions

  • Respiratory Tract Infections
  • Urinary Tract Infections
  • Intra-Abdominal Infections
  • Skin and Soft Tissue Infection
  • Suspected Meningitis/Encephalitis or Any Other Infection
  • Sepsis

Interventions

DIAGNOSTIC_TEST

IMX-BVN-4 and IMX-SEV-4

Blood collection for mRNA analysis, Procalcitonin and CRP determination, molecular analysis of nasopharyngeal swab collection

Sponsors & Collaborators

  • Inflammatix

    lead INDUSTRY

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-31
Primary Completion
2023-04-30
Completion
2023-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05639504 on ClinicalTrials.gov